ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phenazone (Antipyrine) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30S1878
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Phenazone Antipyrine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Phenazone (Antipyrine) Market Research Report 2025

Code: QYRE-Auto-30S1878
Report
September 2025
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Endo
Pfizer Inc
Herbages Naturbec
Bayer
CSPC
Huadong Medicine
Northeast Pharmaceutical
NCPC
Sinopharm
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Tianfang Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shandong Huaxin Pharmaceutical Group
Shandong Xinhua Pharmaceutical
Shandong Fangming Pharmaceutical Group
Shanxi Taiyuan Pharmaceutical
Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
Guangdong Sancai Shiqi District Pharmaceutical
Guangdong Nanguo Pharmaceutical
Kaifeng Pharmaceutical Group
Yuekang Pharmaceutical Group Anhui Biopharmaceutical
Xinxiang Changle Pharmaceutical
Wuhan Fuxing Biopharmaceutical
Henan Runhong Pharmaceutical
Henan Furen Huaiqingtang Pharmaceutical
Hainan Pharmaceutical Factory

Phenazone (Antipyrine) Market

The global market for Phenazone (Antipyrine) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Phenazone (Antipyrine) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Phenazone (Antipyrine) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Phenazone (Antipyrine) in Analytical Reagent for Nitric Acid, Nitrite and Iodine is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Phenazone (Antipyrine) include Endo, Pfizer, Herbages Naturbec, Bayer, CSPC, Huadong Medicine, Northeast Pharmaceutical, NCPC, Sinopharm, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Phenazone (Antipyrine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenazone (Antipyrine).
The Phenazone (Antipyrine) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phenazone (Antipyrine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenazone (Antipyrine) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Phenazone (Antipyrine) Market Report

Report Metric Details
Report Name Phenazone (Antipyrine) Market
Segment by Type
  • Solution
  • Liquid
Segment by Application
  • Analytical Reagent for Nitric Acid, Nitrite and Iodine
  • Antipyretic And Analgesic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Endo, Pfizer, Herbages Naturbec, Bayer, CSPC, Huadong Medicine, Northeast Pharmaceutical, NCPC, Sinopharm, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), Tianfang Pharmaceutical, Tianjin Jinyao Pharmaceutical, Shandong Huaxin Pharmaceutical Group, Shandong Xinhua Pharmaceutical, Shandong Fangming Pharmaceutical Group, Shanxi Taiyuan Pharmaceutical, Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd., Guangdong Sancai Shiqi District Pharmaceutical, Guangdong Nanguo Pharmaceutical, Kaifeng Pharmaceutical Group, Yuekang Pharmaceutical Group Anhui Biopharmaceutical, Xinxiang Changle Pharmaceutical, Wuhan Fuxing Biopharmaceutical, Henan Runhong Pharmaceutical, Henan Furen Huaiqingtang Pharmaceutical, Hainan Pharmaceutical Factory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Phenazone (Antipyrine) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Phenazone (Antipyrine) Market report?

Ans: The main players in the Phenazone (Antipyrine) Market are Endo, Pfizer, Herbages Naturbec, Bayer, CSPC, Huadong Medicine, Northeast Pharmaceutical, NCPC, Sinopharm, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), Tianfang Pharmaceutical, Tianjin Jinyao Pharmaceutical, Shandong Huaxin Pharmaceutical Group, Shandong Xinhua Pharmaceutical, Shandong Fangming Pharmaceutical Group, Shanxi Taiyuan Pharmaceutical, Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd., Guangdong Sancai Shiqi District Pharmaceutical, Guangdong Nanguo Pharmaceutical, Kaifeng Pharmaceutical Group, Yuekang Pharmaceutical Group Anhui Biopharmaceutical, Xinxiang Changle Pharmaceutical, Wuhan Fuxing Biopharmaceutical, Henan Runhong Pharmaceutical, Henan Furen Huaiqingtang Pharmaceutical, Hainan Pharmaceutical Factory

What are the Application segmentation covered in the Phenazone (Antipyrine) Market report?

Ans: The Applications covered in the Phenazone (Antipyrine) Market report are Analytical Reagent for Nitric Acid, Nitrite and Iodine, Antipyretic And Analgesic

What are the Type segmentation covered in the Phenazone (Antipyrine) Market report?

Ans: The Types covered in the Phenazone (Antipyrine) Market report are Solution, Liquid

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenazone (Antipyrine) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solution
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Phenazone (Antipyrine) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Analytical Reagent for Nitric Acid, Nitrite and Iodine
1.3.3 Antipyretic And Analgesic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phenazone (Antipyrine) Market Perspective (2020-2031)
2.2 Global Phenazone (Antipyrine) Growth Trends by Region
2.2.1 Global Phenazone (Antipyrine) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Phenazone (Antipyrine) Historic Market Size by Region (2020-2025)
2.2.3 Phenazone (Antipyrine) Forecasted Market Size by Region (2026-2031)
2.3 Phenazone (Antipyrine) Market Dynamics
2.3.1 Phenazone (Antipyrine) Industry Trends
2.3.2 Phenazone (Antipyrine) Market Drivers
2.3.3 Phenazone (Antipyrine) Market Challenges
2.3.4 Phenazone (Antipyrine) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phenazone (Antipyrine) Players by Revenue
3.1.1 Global Top Phenazone (Antipyrine) Players by Revenue (2020-2025)
3.1.2 Global Phenazone (Antipyrine) Revenue Market Share by Players (2020-2025)
3.2 Global Phenazone (Antipyrine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Phenazone (Antipyrine) Revenue
3.4 Global Phenazone (Antipyrine) Market Concentration Ratio
3.4.1 Global Phenazone (Antipyrine) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenazone (Antipyrine) Revenue in 2024
3.5 Global Key Players of Phenazone (Antipyrine) Head office and Area Served
3.6 Global Key Players of Phenazone (Antipyrine), Product and Application
3.7 Global Key Players of Phenazone (Antipyrine), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Phenazone (Antipyrine) Breakdown Data by Type
4.1 Global Phenazone (Antipyrine) Historic Market Size by Type (2020-2025)
4.2 Global Phenazone (Antipyrine) Forecasted Market Size by Type (2026-2031)
5 Phenazone (Antipyrine) Breakdown Data by Application
5.1 Global Phenazone (Antipyrine) Historic Market Size by Application (2020-2025)
5.2 Global Phenazone (Antipyrine) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Phenazone (Antipyrine) Market Size (2020-2031)
6.2 North America Phenazone (Antipyrine) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Phenazone (Antipyrine) Market Size by Country (2020-2025)
6.4 North America Phenazone (Antipyrine) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phenazone (Antipyrine) Market Size (2020-2031)
7.2 Europe Phenazone (Antipyrine) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Phenazone (Antipyrine) Market Size by Country (2020-2025)
7.4 Europe Phenazone (Antipyrine) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phenazone (Antipyrine) Market Size (2020-2031)
8.2 Asia-Pacific Phenazone (Antipyrine) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2020-2025)
8.4 Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phenazone (Antipyrine) Market Size (2020-2031)
9.2 Latin America Phenazone (Antipyrine) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Phenazone (Antipyrine) Market Size by Country (2020-2025)
9.4 Latin America Phenazone (Antipyrine) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phenazone (Antipyrine) Market Size (2020-2031)
10.2 Middle East & Africa Phenazone (Antipyrine) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2020-2025)
10.4 Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Endo
11.1.1 Endo Company Details
11.1.2 Endo Business Overview
11.1.3 Endo Phenazone (Antipyrine) Introduction
11.1.4 Endo Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.1.5 Endo Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phenazone (Antipyrine) Introduction
11.2.4 Pfizer Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Herbages Naturbec
11.3.1 Herbages Naturbec Company Details
11.3.2 Herbages Naturbec Business Overview
11.3.3 Herbages Naturbec Phenazone (Antipyrine) Introduction
11.3.4 Herbages Naturbec Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.3.5 Herbages Naturbec Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Phenazone (Antipyrine) Introduction
11.4.4 Bayer Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.4.5 Bayer Recent Development
11.5 CSPC
11.5.1 CSPC Company Details
11.5.2 CSPC Business Overview
11.5.3 CSPC Phenazone (Antipyrine) Introduction
11.5.4 CSPC Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.5.5 CSPC Recent Development
11.6 Huadong Medicine
11.6.1 Huadong Medicine Company Details
11.6.2 Huadong Medicine Business Overview
11.6.3 Huadong Medicine Phenazone (Antipyrine) Introduction
11.6.4 Huadong Medicine Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.6.5 Huadong Medicine Recent Development
11.7 Northeast Pharmaceutical
11.7.1 Northeast Pharmaceutical Company Details
11.7.2 Northeast Pharmaceutical Business Overview
11.7.3 Northeast Pharmaceutical Phenazone (Antipyrine) Introduction
11.7.4 Northeast Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.7.5 Northeast Pharmaceutical Recent Development
11.8 NCPC
11.8.1 NCPC Company Details
11.8.2 NCPC Business Overview
11.8.3 NCPC Phenazone (Antipyrine) Introduction
11.8.4 NCPC Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.8.5 NCPC Recent Development
11.9 Sinopharm
11.9.1 Sinopharm Company Details
11.9.2 Sinopharm Business Overview
11.9.3 Sinopharm Phenazone (Antipyrine) Introduction
11.9.4 Sinopharm Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.9.5 Sinopharm Recent Development
11.10 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.10.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
11.10.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.10.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Introduction
11.10.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.10.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.11 Tianfang Pharmaceutical
11.11.1 Tianfang Pharmaceutical Company Details
11.11.2 Tianfang Pharmaceutical Business Overview
11.11.3 Tianfang Pharmaceutical Phenazone (Antipyrine) Introduction
11.11.4 Tianfang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.11.5 Tianfang Pharmaceutical Recent Development
11.12 Tianjin Jinyao Pharmaceutical
11.12.1 Tianjin Jinyao Pharmaceutical Company Details
11.12.2 Tianjin Jinyao Pharmaceutical Business Overview
11.12.3 Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Introduction
11.12.4 Tianjin Jinyao Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.12.5 Tianjin Jinyao Pharmaceutical Recent Development
11.13 Shandong Huaxin Pharmaceutical Group
11.13.1 Shandong Huaxin Pharmaceutical Group Company Details
11.13.2 Shandong Huaxin Pharmaceutical Group Business Overview
11.13.3 Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Introduction
11.13.4 Shandong Huaxin Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.13.5 Shandong Huaxin Pharmaceutical Group Recent Development
11.14 Shandong Xinhua Pharmaceutical
11.14.1 Shandong Xinhua Pharmaceutical Company Details
11.14.2 Shandong Xinhua Pharmaceutical Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Introduction
11.14.4 Shandong Xinhua Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.14.5 Shandong Xinhua Pharmaceutical Recent Development
11.15 Shandong Fangming Pharmaceutical Group
11.15.1 Shandong Fangming Pharmaceutical Group Company Details
11.15.2 Shandong Fangming Pharmaceutical Group Business Overview
11.15.3 Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Introduction
11.15.4 Shandong Fangming Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.15.5 Shandong Fangming Pharmaceutical Group Recent Development
11.16 Shanxi Taiyuan Pharmaceutical
11.16.1 Shanxi Taiyuan Pharmaceutical Company Details
11.16.2 Shanxi Taiyuan Pharmaceutical Business Overview
11.16.3 Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Introduction
11.16.4 Shanxi Taiyuan Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.16.5 Shanxi Taiyuan Pharmaceutical Recent Development
11.17 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
11.17.1 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Company Details
11.17.2 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Business Overview
11.17.3 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Introduction
11.17.4 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.17.5 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Recent Development
11.18 Guangdong Sancai Shiqi District Pharmaceutical
11.18.1 Guangdong Sancai Shiqi District Pharmaceutical Company Details
11.18.2 Guangdong Sancai Shiqi District Pharmaceutical Business Overview
11.18.3 Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Introduction
11.18.4 Guangdong Sancai Shiqi District Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.18.5 Guangdong Sancai Shiqi District Pharmaceutical Recent Development
11.19 Guangdong Nanguo Pharmaceutical
11.19.1 Guangdong Nanguo Pharmaceutical Company Details
11.19.2 Guangdong Nanguo Pharmaceutical Business Overview
11.19.3 Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Introduction
11.19.4 Guangdong Nanguo Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.19.5 Guangdong Nanguo Pharmaceutical Recent Development
11.20 Kaifeng Pharmaceutical Group
11.20.1 Kaifeng Pharmaceutical Group Company Details
11.20.2 Kaifeng Pharmaceutical Group Business Overview
11.20.3 Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Introduction
11.20.4 Kaifeng Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.20.5 Kaifeng Pharmaceutical Group Recent Development
11.21 Yuekang Pharmaceutical Group Anhui Biopharmaceutical
11.21.1 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Company Details
11.21.2 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Business Overview
11.21.3 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Introduction
11.21.4 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.21.5 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Recent Development
11.22 Xinxiang Changle Pharmaceutical
11.22.1 Xinxiang Changle Pharmaceutical Company Details
11.22.2 Xinxiang Changle Pharmaceutical Business Overview
11.22.3 Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Introduction
11.22.4 Xinxiang Changle Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.22.5 Xinxiang Changle Pharmaceutical Recent Development
11.23 Wuhan Fuxing Biopharmaceutical
11.23.1 Wuhan Fuxing Biopharmaceutical Company Details
11.23.2 Wuhan Fuxing Biopharmaceutical Business Overview
11.23.3 Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Introduction
11.23.4 Wuhan Fuxing Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.23.5 Wuhan Fuxing Biopharmaceutical Recent Development
11.24 Henan Runhong Pharmaceutical
11.24.1 Henan Runhong Pharmaceutical Company Details
11.24.2 Henan Runhong Pharmaceutical Business Overview
11.24.3 Henan Runhong Pharmaceutical Phenazone (Antipyrine) Introduction
11.24.4 Henan Runhong Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.24.5 Henan Runhong Pharmaceutical Recent Development
11.25 Henan Furen Huaiqingtang Pharmaceutical
11.25.1 Henan Furen Huaiqingtang Pharmaceutical Company Details
11.25.2 Henan Furen Huaiqingtang Pharmaceutical Business Overview
11.25.3 Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Introduction
11.25.4 Henan Furen Huaiqingtang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.25.5 Henan Furen Huaiqingtang Pharmaceutical Recent Development
11.26 Hainan Pharmaceutical Factory
11.26.1 Hainan Pharmaceutical Factory Company Details
11.26.2 Hainan Pharmaceutical Factory Business Overview
11.26.3 Hainan Pharmaceutical Factory Phenazone (Antipyrine) Introduction
11.26.4 Hainan Pharmaceutical Factory Revenue in Phenazone (Antipyrine) Business (2020-2025)
11.26.5 Hainan Pharmaceutical Factory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Endo
Pfizer Inc
Herbages Naturbec
Bayer
CSPC
Huadong Medicine
Northeast Pharmaceutical
NCPC
Sinopharm
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Tianfang Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shandong Huaxin Pharmaceutical Group
Shandong Xinhua Pharmaceutical
Shandong Fangming Pharmaceutical Group
Shanxi Taiyuan Pharmaceutical
Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
Guangdong Sancai Shiqi District Pharmaceutical
Guangdong Nanguo Pharmaceutical
Kaifeng Pharmaceutical Group
Yuekang Pharmaceutical Group Anhui Biopharmaceutical
Xinxiang Changle Pharmaceutical
Wuhan Fuxing Biopharmaceutical
Henan Runhong Pharmaceutical
Henan Furen Huaiqingtang Pharmaceutical
Hainan Pharmaceutical Factory
List of Tables
 Table 1. Global Phenazone (Antipyrine) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Solution
 Table 3. Key Players of Liquid
 Table 4. Global Phenazone (Antipyrine) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Phenazone (Antipyrine) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Phenazone (Antipyrine) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Phenazone (Antipyrine) Market Share by Region (2020-2025)
 Table 8. Global Phenazone (Antipyrine) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Phenazone (Antipyrine) Market Share by Region (2026-2031)
 Table 10. Phenazone (Antipyrine) Market Trends
 Table 11. Phenazone (Antipyrine) Market Drivers
 Table 12. Phenazone (Antipyrine) Market Challenges
 Table 13. Phenazone (Antipyrine) Market Restraints
 Table 14. Global Phenazone (Antipyrine) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Phenazone (Antipyrine) Market Share by Players (2020-2025)
 Table 16. Global Top Phenazone (Antipyrine) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenazone (Antipyrine) as of 2024)
 Table 17. Ranking of Global Top Phenazone (Antipyrine) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Phenazone (Antipyrine) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Phenazone (Antipyrine), Headquarters and Area Served
 Table 20. Global Key Players of Phenazone (Antipyrine), Product and Application
 Table 21. Global Key Players of Phenazone (Antipyrine), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Phenazone (Antipyrine) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Phenazone (Antipyrine) Revenue Market Share by Type (2020-2025)
 Table 25. Global Phenazone (Antipyrine) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Phenazone (Antipyrine) Revenue Market Share by Type (2026-2031)
 Table 27. Global Phenazone (Antipyrine) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Phenazone (Antipyrine) Revenue Market Share by Application (2020-2025)
 Table 29. Global Phenazone (Antipyrine) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Phenazone (Antipyrine) Revenue Market Share by Application (2026-2031)
 Table 31. North America Phenazone (Antipyrine) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Phenazone (Antipyrine) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Phenazone (Antipyrine) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Phenazone (Antipyrine) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Phenazone (Antipyrine) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Phenazone (Antipyrine) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Phenazone (Antipyrine) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Phenazone (Antipyrine) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Phenazone (Antipyrine) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Phenazone (Antipyrine) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Phenazone (Antipyrine) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Endo Company Details
 Table 47. Endo Business Overview
 Table 48. Endo Phenazone (Antipyrine) Product
 Table 49. Endo Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 50. Endo Recent Development
 Table 51. Pfizer Company Details
 Table 52. Pfizer Business Overview
 Table 53. Pfizer Phenazone (Antipyrine) Product
 Table 54. Pfizer Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 55. Pfizer Recent Development
 Table 56. Herbages Naturbec Company Details
 Table 57. Herbages Naturbec Business Overview
 Table 58. Herbages Naturbec Phenazone (Antipyrine) Product
 Table 59. Herbages Naturbec Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 60. Herbages Naturbec Recent Development
 Table 61. Bayer Company Details
 Table 62. Bayer Business Overview
 Table 63. Bayer Phenazone (Antipyrine) Product
 Table 64. Bayer Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 65. Bayer Recent Development
 Table 66. CSPC Company Details
 Table 67. CSPC Business Overview
 Table 68. CSPC Phenazone (Antipyrine) Product
 Table 69. CSPC Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 70. CSPC Recent Development
 Table 71. Huadong Medicine Company Details
 Table 72. Huadong Medicine Business Overview
 Table 73. Huadong Medicine Phenazone (Antipyrine) Product
 Table 74. Huadong Medicine Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 75. Huadong Medicine Recent Development
 Table 76. Northeast Pharmaceutical Company Details
 Table 77. Northeast Pharmaceutical Business Overview
 Table 78. Northeast Pharmaceutical Phenazone (Antipyrine) Product
 Table 79. Northeast Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 80. Northeast Pharmaceutical Recent Development
 Table 81. NCPC Company Details
 Table 82. NCPC Business Overview
 Table 83. NCPC Phenazone (Antipyrine) Product
 Table 84. NCPC Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 85. NCPC Recent Development
 Table 86. Sinopharm Company Details
 Table 87. Sinopharm Business Overview
 Table 88. Sinopharm Phenazone (Antipyrine) Product
 Table 89. Sinopharm Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 90. Sinopharm Recent Development
 Table 91. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
 Table 92. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
 Table 93. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Product
 Table 94. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 95. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
 Table 96. Tianfang Pharmaceutical Company Details
 Table 97. Tianfang Pharmaceutical Business Overview
 Table 98. Tianfang Pharmaceutical Phenazone (Antipyrine) Product
 Table 99. Tianfang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 100. Tianfang Pharmaceutical Recent Development
 Table 101. Tianjin Jinyao Pharmaceutical Company Details
 Table 102. Tianjin Jinyao Pharmaceutical Business Overview
 Table 103. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Product
 Table 104. Tianjin Jinyao Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 105. Tianjin Jinyao Pharmaceutical Recent Development
 Table 106. Shandong Huaxin Pharmaceutical Group Company Details
 Table 107. Shandong Huaxin Pharmaceutical Group Business Overview
 Table 108. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Product
 Table 109. Shandong Huaxin Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 110. Shandong Huaxin Pharmaceutical Group Recent Development
 Table 111. Shandong Xinhua Pharmaceutical Company Details
 Table 112. Shandong Xinhua Pharmaceutical Business Overview
 Table 113. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Product
 Table 114. Shandong Xinhua Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 115. Shandong Xinhua Pharmaceutical Recent Development
 Table 116. Shandong Fangming Pharmaceutical Group Company Details
 Table 117. Shandong Fangming Pharmaceutical Group Business Overview
 Table 118. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Product
 Table 119. Shandong Fangming Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 120. Shandong Fangming Pharmaceutical Group Recent Development
 Table 121. Shanxi Taiyuan Pharmaceutical Company Details
 Table 122. Shanxi Taiyuan Pharmaceutical Business Overview
 Table 123. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Product
 Table 124. Shanxi Taiyuan Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 125. Shanxi Taiyuan Pharmaceutical Recent Development
 Table 126. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Company Details
 Table 127. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Business Overview
 Table 128. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Product
 Table 129. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 130. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Recent Development
 Table 131. Guangdong Sancai Shiqi District Pharmaceutical Company Details
 Table 132. Guangdong Sancai Shiqi District Pharmaceutical Business Overview
 Table 133. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Product
 Table 134. Guangdong Sancai Shiqi District Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 135. Guangdong Sancai Shiqi District Pharmaceutical Recent Development
 Table 136. Guangdong Nanguo Pharmaceutical Company Details
 Table 137. Guangdong Nanguo Pharmaceutical Business Overview
 Table 138. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Product
 Table 139. Guangdong Nanguo Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 140. Guangdong Nanguo Pharmaceutical Recent Development
 Table 141. Kaifeng Pharmaceutical Group Company Details
 Table 142. Kaifeng Pharmaceutical Group Business Overview
 Table 143. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Product
 Table 144. Kaifeng Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 145. Kaifeng Pharmaceutical Group Recent Development
 Table 146. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Company Details
 Table 147. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Business Overview
 Table 148. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Product
 Table 149. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 150. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Recent Development
 Table 151. Xinxiang Changle Pharmaceutical Company Details
 Table 152. Xinxiang Changle Pharmaceutical Business Overview
 Table 153. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Product
 Table 154. Xinxiang Changle Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 155. Xinxiang Changle Pharmaceutical Recent Development
 Table 156. Wuhan Fuxing Biopharmaceutical Company Details
 Table 157. Wuhan Fuxing Biopharmaceutical Business Overview
 Table 158. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Product
 Table 159. Wuhan Fuxing Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 160. Wuhan Fuxing Biopharmaceutical Recent Development
 Table 161. Henan Runhong Pharmaceutical Company Details
 Table 162. Henan Runhong Pharmaceutical Business Overview
 Table 163. Henan Runhong Pharmaceutical Phenazone (Antipyrine) Product
 Table 164. Henan Runhong Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 165. Henan Runhong Pharmaceutical Recent Development
 Table 166. Henan Furen Huaiqingtang Pharmaceutical Company Details
 Table 167. Henan Furen Huaiqingtang Pharmaceutical Business Overview
 Table 168. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Product
 Table 169. Henan Furen Huaiqingtang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 170. Henan Furen Huaiqingtang Pharmaceutical Recent Development
 Table 171. Hainan Pharmaceutical Factory Company Details
 Table 172. Hainan Pharmaceutical Factory Business Overview
 Table 173. Hainan Pharmaceutical Factory Phenazone (Antipyrine) Product
 Table 174. Hainan Pharmaceutical Factory Revenue in Phenazone (Antipyrine) Business (2020-2025) & (US$ Million)
 Table 175. Hainan Pharmaceutical Factory Recent Development
 Table 176. Research Programs/Design for This Report
 Table 177. Key Data Information from Secondary Sources
 Table 178. Key Data Information from Primary Sources
 Table 179. Authors List of This Report


List of Figures
 Figure 1. Phenazone (Antipyrine) Picture
 Figure 2. Global Phenazone (Antipyrine) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Phenazone (Antipyrine) Market Share by Type: 2024 VS 2031
 Figure 4. Solution Features
 Figure 5. Liquid Features
 Figure 6. Global Phenazone (Antipyrine) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Phenazone (Antipyrine) Market Share by Application: 2024 VS 2031
 Figure 8. Analytical Reagent for Nitric Acid, Nitrite and Iodine Case Studies
 Figure 9. Antipyretic And Analgesic Case Studies
 Figure 10. Phenazone (Antipyrine) Report Years Considered
 Figure 11. Global Phenazone (Antipyrine) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Phenazone (Antipyrine) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Phenazone (Antipyrine) Market Share by Region: 2024 VS 2031
 Figure 14. Global Phenazone (Antipyrine) Market Share by Players in 2024
 Figure 15. Global Top Phenazone (Antipyrine) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenazone (Antipyrine) as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Phenazone (Antipyrine) Revenue in 2024
 Figure 17. North America Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Phenazone (Antipyrine) Market Share by Country (2020-2031)
 Figure 19. United States Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Phenazone (Antipyrine) Market Share by Country (2020-2031)
 Figure 23. Germany Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Phenazone (Antipyrine) Market Share by Region (2020-2031)
 Figure 31. China Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Phenazone (Antipyrine) Market Share by Country (2020-2031)
 Figure 39. Mexico Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Phenazone (Antipyrine) Market Share by Country (2020-2031)
 Figure 43. Turkey Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Phenazone (Antipyrine) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Endo Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 47. Pfizer Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 48. Herbages Naturbec Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 49. Bayer Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 50. CSPC Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 51. Huadong Medicine Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 52. Northeast Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 53. NCPC Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 54. Sinopharm Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 55. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 56. Tianfang Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 57. Tianjin Jinyao Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 58. Shandong Huaxin Pharmaceutical Group Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 59. Shandong Xinhua Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 60. Shandong Fangming Pharmaceutical Group Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 61. Shanxi Taiyuan Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 62. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 63. Guangdong Sancai Shiqi District Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 64. Guangdong Nanguo Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 65. Kaifeng Pharmaceutical Group Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 66. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 67. Xinxiang Changle Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 68. Wuhan Fuxing Biopharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 69. Henan Runhong Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 70. Henan Furen Huaiqingtang Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 71. Hainan Pharmaceutical Factory Revenue Growth Rate in Phenazone (Antipyrine) Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Phenylbutazone API Market Research Report 2024
Global Dithizone Market Research Report 2025
Global Pyrazine Market Research Report 2025
Global Pioglitazone HCL Market Research Report 2024
Global Antipyretic Paste Market Research Report 2025
Global Benzophenone Hydrazone Market Research Report 2025
Global Acetylpyrazine Market Research Report 2025
Global Dioxybenzone Market Research Report 2025
Global Pyrazinamide Market Research Report 2025
Global Anti anemia Drugs Market Research Report 2024
Global Eprazinone Market Research Report 2024
Global Antigout Agent Market Research Report 2024
Global Sulfentrazone Market Research Report 2025
Global Antipyretic and Analgesic API Market Research Report 2024
Global Antimetabolite Drugs Market Research Report 2024
Chlorzoxazone Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Sugar Pill Market Research Report 2024
Global Pioglitazone Hydrochloride Market Research Report 2025
Global Pirfenidone Market Research Report 2024
Global Xylazine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions